- Filed
- Feb 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 21, 2025 | 412.3M sh |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | $470.95M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $661.84M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $32.31M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $107.57M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $977.16M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $1.08B |
| Current Assets | FY 2024 · Dec 31, 2023 | $1.48B |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.74B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 408.15M sh |
| Capex | FY 2024 · Dec 31, 2022 | $15.43M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$130.81M |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $207.79M |
| Net Income | FY 2024 · Dec 31, 2022 | −$106.55M |
| Operating Income restated | FY 2024 · Dec 31, 2022 | −$105.38M |
| Revenue restated | FY 2024 · Dec 31, 2022 | $2.39B |